NYSE, BCR - C.R. Bard
C. R. Bard, Inc. (the ?company? or ?Bard?) is engaged in the design,
manufacture, packaging, distribution and sale of medical, surgical, diagnostic
and patient care devices. Charles Russell Bard founded the company in 1907. In
1923, the company was incorporated as C. R. Bard, Inc. and distributed an
assortment of urological and surgical products. Bard became a publicly traded
company in 1963 and began trading on the New York Stock Exchange five years
later. The company sells a broad range of products worldwide to hospitals,
individual healthcare professionals, extended care facilities and alternate site
facilities. In general, Bard?s products are intended to be used once and then
discarded or implanted either temporarily or permanently. The company holds
market leading positions in vascular, urology, oncology and surgical specialty
products. ...
Read SEC Filing on NASDAQ.com »